ClinicalTrials.gg
CompletedNCT03270683DOTACUpdated Dec 27, 2019

Doppler Sonography of Cerebral Blood Flow for Early Prognostication After Out-of-hospital Cardiac Arrest

An observational study in Cardiac Arrest, sponsored by Rennes University Hospital. Completed at 1 site in France. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2019-12-27.

Sponsored by Rennes University Hospital · Observational

Study type
Observational
Model
Case-control
Time perspective
Prospective
Enrollment
52
Ages
18 Years and older
Sex
All
01

Study summary

Objective: To assess neurologic prognostication by early Transcranial Doppler Sonography (TCD) in comatose survivors after cardiac arrest.

Design: Prospective study between May 2016 and November 2017 in a medical intensive care unit and cardiac intensive care unit in a university hospital.

Patients: all comatose patients older than 18 years successfully resuscitated from an out-of-hospital cardiac arrest (OHCA). Patients for whom OHCA is associated with traumatic brain injury, no window for TCD measurements, or dead before neurological prognostication are excluded.

Read the detailed description

The investigators measure the pulsatility index (PI) and diastolic flow velocity (DFV) of the right and left middle cerebral artery during the first 12 h after return of spontaneous circulation (ROSC). The highest value of DFV and the lowest of PI will use for the statistical analysis. Cerebral Performance Category evaluate neurologic outcome at hospital discharge.

Data provided by early TCD after ROSC are associated with neurological outcome. The use of these data could lead to the development of therapeutics improving cerebral perfusion in patient resuscitated from an OHCA.

02

Conditions studied

  • Cardiac Arrest

Keywords

  • Out-of-hospital cardiac arrest
  • transcranial Doppler sonography
  • cerebrovascular circulation
  • prognosis
03

In context

Heart Arrest

984 studies on the registry are indexed under Heart Arrest; 227 are open to participants now.

This study's enrollment of 52 is below the median of 196 across 394 observational studies indexed under Heart Arrest.

Browse Heart Arrest studies →

Lead sponsor

Rennes University Hospital is the lead sponsor of 451 studies on the registry; 51 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Patients resuscitated from out-of-hospital cardiac arrest

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • older 18 years
  • out-of-hospital cardiac arrest with recovery of spontaneous cardiac activity

Exclusion criteria

Exclusion Criteria:

  • transcranial doppler not done or not interpretable
  • associated cranial trauma
  • died without neurological assessment
05

Study design

Observational model
Case-control
Time perspective
Prospective
Enrollment
52 participants (actual)
Patient registry
No
06

What researchers measure

Primary outcomes

  1. Evaluate the relation between TCD measurements and neurologic outcome at hospital discharge

    Good score = CPC 1-2 and bad score = CPC 3-5

    Time frame: 6 months

Secondary outcomes

  1. Measurement of pulsatility index

    Evaluate the association between pulsatility index and period of cardiac arrest

    Time frame: 12 hours

  2. Entry of doppler parameters

    Identify a doppler parameter than can improve the neurological outcome

    Time frame: 6 months

07

Study locations

1 site
  • CHU Rennes
    Rennes, France
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Dec 27, 2019, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT03270683
Responsible party
Sponsor
First posted
Sep 1, 2017
Start date
May 2, 2016
Primary completion
Oct 2017
Completion
Oct 2017
Last update
Dec 27, 2019

Study contacts

Adel Maamar, Dr
principal investigator · Rennes University Hospital

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Dec 2019. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion